BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3838290)

  • 1. Radiotherapy and/or chemotherapy as adjuvant treatment of uterine sarcomas.
    Sorbe B
    Gynecol Oncol; 1985 Mar; 20(3):281-9. PubMed ID: 3838290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant chemotherapy in early uterine sarcoma.
    Hannigan EV; Freedman RS; Rutledge FN
    Gynecol Oncol; 1983 Feb; 15(1):56-64. PubMed ID: 6401640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant therapy for stage I uterine sarcoma.
    Rose PG; Boutselis JG; Sachs L
    Am J Obstet Gynecol; 1987 Mar; 156(3):660-2. PubMed ID: 3826216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of adjuvant CYVADIC chemotherapy in early-stage uterine sarcomas: results of long-term follow-up.
    Odunsi K; Moneke V; Tammela J; Ghamande S; Seago P; Driscoll D; Marchetti D; Baker T; Lele S
    Int J Gynecol Cancer; 2004; 14(4):659-64. PubMed ID: 15304162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the apparent failure of adjuvant pelvic radiotherapy to improve survival for women with uterine sarcomas confined to the uterus.
    Dusenbery KE; Potish RA; Argenta PA; Judson PL
    Am J Clin Oncol; 2005 Jun; 28(3):295-300. PubMed ID: 15923804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact on progression-free survival of adjuvant cyclophosphamide, vincristine, doxorubicin (adriamycin), and dacarbazine (CYVADIC) chemotherapy for stage I uterine sarcoma. A prospective trial.
    Hempling RE; Piver MS; Baker TR
    Am J Clin Oncol; 1995 Aug; 18(4):282-6. PubMed ID: 7625366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy in early stage uterine sarcomas: an open question.
    Gadducci A; Romanini A
    Eur J Gynaecol Oncol; 2001; 22(5):352-7. PubMed ID: 11766739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Uterine sarcoma. Retrospective analysis of a series of 22 cases].
    Mage P; Chauvergne J; Bui NB; Avril A; Trojani M; Richaud P; Germain T; Maree D
    J Gynecol Obstet Biol Reprod (Paris); 1984; 13(7):802-7. PubMed ID: 6549321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of adjuvant chemotherapy in the treatment of uterine sarcoma patients.
    Töre G; Topuz E; Bilce N; Aslay I; Dinçer M; Elgin A
    Eur J Gynaecol Oncol; 1990; 11(4):307-12. PubMed ID: 2245816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma Group.
    Pautier P; Floquet A; Gladieff L; Bompas E; Ray-Coquard I; Piperno-Neumann S; Selle F; Guillemet C; Weber B; Largillier R; Bertucci F; Opinel P; Duffaud F; Reynaud-Bougnoux A; Delcambre C; Isambert N; Kerbrat P; Netter-Pinon G; Pinto N; Duvillard P; Haie-Meder C; Lhommé C; Rey A
    Ann Oncol; 2013 Apr; 24(4):1099-104. PubMed ID: 23139262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant management of operated uterine sarcomas: A single institution experience.
    Cordoba A; Prades J; Basson L; Robin YM; Taïeb S; Narducci F; Hudry D; Bresson L; Chevalier A; Le Tinier F; Mirabel X; Lartigau É; Penel N; Leblanc É
    Cancer Radiother; 2019 Sep; 23(5):401-407. PubMed ID: 31351809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limitations of adjuvant radiotherapy for uterine sarcomas spread beyond the uterus.
    Dusenbery KE; Potish RA; Judson P
    Gynecol Oncol; 2004 Jul; 94(1):191-6. PubMed ID: 15262141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of adjuvant chemotherapy on time to recurrence and survival of stage I uterine sarcomas.
    Piver MS; Lele SB; Marchetti DL; Emrich LJ
    J Surg Oncol; 1988 Aug; 38(4):233-9. PubMed ID: 3045423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy following surgery in the management of uterine sarcomas.
    Szánthó A; Bálega J; Szabó I; Demeter A; Sipos N; Csapó Z; Papp Z
    Eur J Gynaecol Oncol; 2003; 24(5):421-4. PubMed ID: 14584661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic results in uterine sarcoma (1955-1985)].
    Köhler U; Spröwitz M; Richter R; Bilek K; Forberg J
    Zentralbl Gynakol; 1988; 110(20):283-9. PubMed ID: 3239303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined irradiation and chemotherapy for sarcomas of the pelvis in females.
    Smith JP; Rutledge F; Delclos L; Sutow W
    Am J Roentgenol Radium Ther Nucl Med; 1975 Mar; 123(3):571-6. PubMed ID: 164783
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of radiotherapy treatment of uterine sarcoma.
    Sampath S; Gaffney DK
    Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):761-72. PubMed ID: 21783424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of soft tissue sarcomas with focus on chemotherapy: a review.
    Pinedo HM; Verweij J
    Radiother Oncol; 1986 Mar; 5(3):193-205. PubMed ID: 3517971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of adjuvant chemotherapy in the management of sarcomas in children.
    Donaldson SS
    Cancer; 1985 May; 55(9 Suppl):2184-97. PubMed ID: 3884137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soft tissue sarcomas. Is adjuvant chemotherapy indicated?
    Guron G; Neugut AI
    N Y State J Med; 1993 Mar; 93(3):156-8. PubMed ID: 8455843
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.